GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VTYX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ventyx Biosciences, Inc. stock price ended at $4.35 on Thursday, after losing 0.685%.
(Updated on Apr 18, 2024)

Sell candidate since Apr 08, 2024 Loss -7.84% PDF

The Ventyx Biosciences, Inc. stock price fell by -0.685% on the last day (Thursday, 18th Apr 2024) from $4.38 to $4.35. During the last trading day the stock fluctuated 5.79% from a day low at $4.24 to a day high of $4.48. The price has fallen in 6 of the last 10 days and is down by -11.22% for this period. Volume has increased on the last day by 68 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 837 thousand shares were bought and sold for approximately $3.64 million.

Given the current short-term trend, the stock is expected to rise 54.64% during the next 3 months and, with a 90% probability hold a price between $6.73 and $18.77 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VTYX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ventyx Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.59 and $6.61. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -57.06%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Ventyx Biosciences, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.245 between high and low, or 5.79%. For the last week, the stock has had daily average volatility of 5.90%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VTYX) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Ventyx Biosciences, Inc. to open at $4.36, and during the day (based on 14 day Average True Range), to move between $3.83 and $4.87, which gives a possible trading interval of +/-$0.516 (+/-11.85%) up or down from last closing price. If Ventyx Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 23.70% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $4.60, some $0.250 (5.75%) from the current price of $4.35, our system finds the risk reward not very attractive.

Is Ventyx Biosciences, Inc. stock A Buy?

The Ventyx Biosciences, Inc. stock holds several negative signals and despite the positive trend, we believe Ventyx Biosciences, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.556 Sell Candidate Unchanged

Predicted Opening Price for Ventyx Biosciences, Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$4.36 ( 0.115%) $4.35

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VTYX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.60 5.75 %
R2 4.51 3.60 %
R1 4.45 2.27 %
Current price: 4.35
Support S1 4.26 -2.04 %
S2 4.20 -3.37 %
S3 4.11 -5.52 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.24 20.46 %
R2 5.04 15.86 %
R1 4.60 5.75 %
Current price 4.35
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Ventyx Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Ventyx Biosciences, Inc. is VTYX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ventyx Biosciences, Inc. Stock?
The Ventyx Biosciences, Inc. stock holds several negative signals and despite the positive trend, we believe Ventyx Biosciences, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Ventyx Biosciences, Inc. Stock?
Ventyx Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ventyx Biosciences, Inc. Stock.

What's the current price of Ventyx Biosciences, Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Ventyx Biosciences, Inc. (VTYX) share was $4.35.

What is the 52-week high and low for Ventyx Biosciences, Inc. Stock?
The 52-week high for Ventyx Biosciences, Inc. Stock is $40.58 and the 52-week low is $1.87.

What is the market capitalization of Ventyx Biosciences, Inc. Stock?
As of the 2024-04-18, the market capitalization of Ventyx Biosciences, Inc. is 257.748M.

When is the next earnings date for Ventyx Biosciences, Inc.?
The upcoming earnings date for Ventyx Biosciences, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Ventyx Biosciences, Inc.

Ventyx Biosciences. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002,... VTYX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT